During the past decade, Tri-State Urologic Services conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tri-State Urologic Services" are "Abiraterone Acetate" (1 trials), "Androgens" (1 trials), "Antineoplastic Agents" (1 trials), "Antineoplastic Agents, Hormonal" (1 trials) and "Cyclin-Dependent Kinase 4" (1 trials). Many other conditions were trialed in "Tri-State Urologic Services" in a lesser frequency.

Most popular intervention types in "Tri-State Urologic Services" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone" (2 trials), "Abemaciclib" (1 trials), "Enzalutamide" (1 trials), "GTX-006 (Acapodene)" (1 trials) and "Placebo for Abemaciclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tri-State Urologic Services" are 4 trials for "Male" genders.

Currently, there are NaN active trials in "Tri-State Urologic Services". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Tri-State Urologic Services, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tri-State Urologic Services, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".